[Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD]

Tunçalp Demir; Hakan Günen; Mehmet Polatlı; Nurhayat Yıldırım

doi:10.5578/tt.2620

[Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD]

Tuberk Toraks. 2011;59(1):89-100. doi: 10.5578/tt.2620.

[Article in Turkish]

Authors

Tunçalp Demir¹, Hakan Günen, Mehmet Polatlı, Nurhayat Yıldırım

Affiliation

¹ Clinic of Chest Diseases, Umraniye Training and Research Hospital, Istanbul, Turkey.

PMID: 21554238
DOI: 10.5578/tt.2620

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized with progressive air flow limitation, and is expected to be the third leading cause of death until 2030 worldwide. The clinical trials in the last 10 years revealed that fix combinations (inhaled corticosteroids/long-acting beta-2 agonist; ICS/LABA) improve lung functions and quality of life, and reduced symptoms and exacerbation rates in patients with severe and very severe COPD.

Publication types

English Abstract
Review

MeSH terms

Administration, Inhalation
Adrenal Cortex Hormones / administration & dosage*
Adrenergic beta-2 Receptor Agonists / administration & dosage*
Delayed-Action Preparations
Drug Combinations
Humans
Lung / drug effects
Lung / physiopathology
Pulmonary Disease, Chronic Obstructive / drug therapy*
Pulmonary Disease, Chronic Obstructive / physiopathology
Quality of Life
Severity of Illness Index

Substances

Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists
Delayed-Action Preparations
Drug Combinations